Nicolas Folschweiller

1.1k total citations
28 papers, 635 citations indexed

About

Nicolas Folschweiller is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, Nicolas Folschweiller has authored 28 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 10 papers in Public Health, Environmental and Occupational Health and 9 papers in Infectious Diseases. Recurrent topics in Nicolas Folschweiller's work include Mosquito-borne diseases and control (10 papers), Hepatitis B Virus Studies (10 papers) and Cervical Cancer and HPV Research (8 papers). Nicolas Folschweiller is often cited by papers focused on Mosquito-borne diseases and control (10 papers), Hepatitis B Virus Studies (10 papers) and Cervical Cancer and HPV Research (8 papers). Nicolas Folschweiller collaborates with scholars based in Switzerland, United States and Belgium. Nicolas Folschweiller's co-authors include F. Pattus, Mohamed Abou‐Elwafa Abdallah, Isabelle J. Schalk, Hervé Celia, David Cobessi, Frank Struyf, P.V. Suryakiran, Pierre Van Damme, Olivier Van Der Meeren and Sylviane Poncelet and has published in prestigious journals such as Journal of Molecular Biology, JNCI Journal of the National Cancer Institute and Biochemistry.

In The Last Decade

Nicolas Folschweiller

27 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicolas Folschweiller Switzerland 13 271 194 133 100 88 28 635
Kai Michaelis Germany 14 155 0.6× 336 1.7× 171 1.3× 161 1.6× 113 1.3× 21 837
Leonardo Henrique Ferreira Gomes Brazil 13 145 0.5× 133 0.7× 72 0.5× 147 1.5× 76 0.9× 28 453
Min‐Hsuan Lin Australia 16 91 0.3× 292 1.5× 85 0.6× 175 1.8× 63 0.7× 30 637
Milda Plečkaitytė Lithuania 15 283 1.0× 248 1.3× 48 0.4× 35 0.3× 60 0.7× 35 608
Anna Sintsova United States 15 220 0.8× 341 1.8× 115 0.9× 147 1.5× 115 1.3× 27 786
Christiane Honisch United States 11 177 0.7× 484 2.5× 289 2.2× 159 1.6× 11 0.1× 14 885
Kerri J. Penrose United States 13 173 0.6× 195 1.0× 163 1.2× 162 1.6× 58 0.7× 21 574
Shite Sebastian United States 13 186 0.7× 257 1.3× 185 1.4× 147 1.5× 43 0.5× 22 611
Debashree Chatterjee United States 15 145 0.5× 501 2.6× 159 1.2× 201 2.0× 135 1.5× 30 897
Na Yang China 17 248 0.9× 188 1.0× 30 0.2× 49 0.5× 69 0.8× 44 843

Countries citing papers authored by Nicolas Folschweiller

Since Specialization
Citations

This map shows the geographic impact of Nicolas Folschweiller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Folschweiller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Folschweiller more than expected).

Fields of papers citing papers by Nicolas Folschweiller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Folschweiller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Folschweiller. The network helps show where Nicolas Folschweiller may publish in the future.

Co-authorship network of co-authors of Nicolas Folschweiller

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Folschweiller. A scholar is included among the top collaborators of Nicolas Folschweiller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Folschweiller. Nicolas Folschweiller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anugulruengkitt, Suvaporn, Keswadee Lapphra, Kriengsak Limkittikul, et al.. (2025). Immunogenicity and safety of the live-attenuated tetravalent dengue vaccine (TAK-003) co-administered with recombinant 9-valent human papillomavirus vaccine. Vaccine. 62. 127558–127558.
2.
Alera, Maria Theresa, Lulu Bravo, Edson Duarte Moreira, et al.. (2025). Estimated Efficacy of TAK-003 Against Asymptomatic Dengue Infection in Children and Adolescents Participating in the DEN-301 Trial in Asia Pacific and Latin America. The Journal of Infectious Diseases. 231(6). e1160–e1169. 3 indexed citations
3.
Biswal, Shibadas, et al.. (2024). Early onset of protection of the TAK-003 dengue vaccine: Data from the DEN-301 clinical trial. Vaccine. 42(26). 126309–126309. 7 indexed citations
4.
Fernando, LakKumar, Pujitha Wickramasinghe, Asvini D. Fernando, et al.. (2024). Role of the dengue vaccine TAK-003 in an outbreak response: Modeling the Sri Lanka experience. PLoS neglected tropical diseases. 18(8). e0012376–e0012376. 3 indexed citations
5.
Friberg, Heather, Xavier Sáez‐Llorens, Charissa Borja-Tabora, et al.. (2024). Long term T cell response and safety of a tetravalent dengue vaccine in healthy children. npj Vaccines. 9(1). 192–192. 9 indexed citations
6.
Borja-Tabora, Charissa, LakKumar Fernando, Eduardo López‐Medina, et al.. (2024). Immunogenicity, Safety, and Efficacy of a Tetravalent Dengue Vaccine in Children and Adolescents: An Analysis by Age Group. Clinical Infectious Diseases. 80(1). 199–206. 7 indexed citations
7.
8.
Green, Andrew R., et al.. (2023). EFFICACY AND SAFETY OF TAKEDA'S TETRAVALENT DENGUE VACCINE CANDIDATE (TAK-003) AFTER 4.5 YEARS OF FOLLOW-UP: RESULTS FROM PARTICIPANTS IN ASIA. International Journal of Infectious Diseases. 130. S11–S11. 2 indexed citations
9.
Kotb, Shady, Miwa Haranaka, Nicolas Folschweiller, et al.. (2023). Safety and immunogenicity of a respiratory syncytial virus prefusion F protein (RSVPreF3) candidate vaccine in older Japanese adults: A phase I, randomized, observer-blind clinical trial. Respiratory Investigation. 61(2). 261–269. 11 indexed citations
10.
Sáez‐Llorens, Xavier, Shibadas Biswal, Charissa Borja-Tabora, et al.. (2023). Effect of the Tetravalent Dengue Vaccine TAK-003 on Sequential Episodes of Symptomatic Dengue. American Journal of Tropical Medicine and Hygiene. 108(4). 722–726. 14 indexed citations
11.
Lefevre, Inge, Lulu Bravo, Nicolas Folschweiller, et al.. (2023). Bridging the immunogenicity of a tetravalent dengue vaccine (TAK-003) from children and adolescents to adults. npj Vaccines. 8(1). 75–75. 8 indexed citations
12.
Folschweiller, Nicolas, Carline Vanden Abeele, Laurence Chu, et al.. (2022). Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1–2 randomised controlled trial. The Lancet Infectious Diseases. 22(7). 1062–1075. 17 indexed citations
13.
Schwarz, Tino F., Li‐Min Huang, Alejandra Valencia, et al.. (2019). A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years. Human Vaccines & Immunotherapeutics. 15(7-8). 1970–1979. 45 indexed citations
14.
Tota, Joseph E., Frank Struyf, Joshua N. Sampson, et al.. (2019). Efficacy of the AS04-Adjuvanted HPV16/18 Vaccine: Pooled Analysis of the Costa Rica Vaccine and PATRICIA Randomized Controlled Trials. JNCI Journal of the National Cancer Institute. 112(8). 818–828. 23 indexed citations
15.
16.
17.
Koglin, Markus, et al.. (2005). Characterization of 16 human G protein-coupled receptors expressed in baculovirus-infected insect cells. Protein Expression and Purification. 44(1). 65–74. 51 indexed citations
18.
Cobessi, David, Hervé Celia, Nicolas Folschweiller, et al.. (2005). The Crystal Structure of the Pyoverdine Outer Membrane Receptor FpvA from Pseudomonas aeruginosa at 3.6Å Resolution. Journal of Molecular Biology. 347(1). 121–134. 136 indexed citations
19.
Folschweiller, Nicolas, Hervé Celia, Noëlle Potier, et al.. (2004). In vivo incorporation of selenomethionine in proteins using Pseudomonas aeruginosa as expression host: case study—the outer membrane receptor FpvA. Protein Expression and Purification. 38(1). 79–83. 3 indexed citations
20.
Cobessi, David, Hervé Celia, Nicolas Folschweiller, et al.. (2004). Crystallization and preliminary X-ray analysis of the outer membrane pyoverdine receptor FpvA fromPseudomonas aeruginosa. Acta Crystallographica Section D Biological Crystallography. 60(8). 1467–1469. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kai Michaelis Breakdown of academic impact, for papers by Leonardo Henrique Ferreira Gomes Breakdown of academic impact, for papers by Min‐Hsuan Lin Breakdown of academic impact, for papers by Milda Plečkaitytė Breakdown of academic impact, for papers by Anna Sintsova Breakdown of academic impact, for papers by Christiane Honisch Breakdown of academic impact, for papers by Kerri J. Penrose Breakdown of academic impact, for papers by Shite Sebastian Breakdown of academic impact, for papers by Debashree Chatterjee Breakdown of academic impact, for papers by Na Yang
Rankless by CCL
2026